How much confidence would you have in an Alzheimer’s blood test that incorrectly tells 40% of healthy people they may have the disease? A new FDA-cleared blood test designed to detect Alzheimer’s disease, Fujirebio’s Lumipulse plasma test, is drawing criticism after Mayo Clinic researchers found it produced an alarming number of false-positive results when used in real-world patients. […]
The post Alzheimer’s Disease – Another Big Pharma Goldmine appeared first on Redacted.
